Mr. Harry Kirsch is Chief Financial Officer at Novartis AG.
He is on the Board of Directors at Novartis Institutes for Biomedical Research, Inc. and Novartis International AG. Mr. Kirsch was previously employed as CFO-Global Pharmaceutical Business by Procter & Gamble Co.
He also served on the board at Glaxosmithkline Consumer Healthcare Pte Ltd.
He received his undergraduate degree from Karlsruher Institut für Technologie.